Study shows possible way to regenerate bones using messenger RNA
Researchers at Mayo Clinic, US found that messenger RNA could be used at low doses to regenerate bones without side effects.
List view / Grid view
Researchers at Mayo Clinic, US found that messenger RNA could be used at low doses to regenerate bones without side effects.
A new study has suggested that previous global research into the human microbiome is heavily biased in favour of wealthy countries such as the US and UK.
In a scientific first, researchers have discovered fundamental mechanisms by which the hippocampus region of the brain organises memories into sequences and how this can be used to plan future behaviour.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
A recent study has shown that antiretroviral therapy timing impacts the animal version of HIV and latent tuberculosis.
New research has shown that one-time infusion of stem cells from bone marrow improves the survival of mice with sepsis.
A recent pre-clinical study from Washington University School of Medicine showed that a new class of compounds can potentially improve multiple aspects of metabolic syndrome, including diabetes.
A molecular cage, developed for use during cryo-EM, has provided researchers with new insights into a key cancer protein.
New pre-clinical research from the Université Laval Faculty of Medicine and CHU de Québec–Université Laval Research Centre showed genetically mutating human cells could avoid Alzheimer’s disease.
New research by the University of California, San Diego could provide a much simpler way to repair disease-causing mutations in RNA.
Researchers have made a respiratory model of COVID-19, made from patient-derived stem cells, to understand how the virus affects respiration and which could be used to test possible drugs.
Researchers at UC Davis Health have engineered an antibody that interferes with a critical cell mechanism to reduce transmission of the virus that causes COVID-19 in lab tests.
By identifying a mechanism behind bone strengthening in response to stress, researchers have found a possible new target for treating conditions that weaken bones.
Using chemical genetic screening and pre-clinical model studies, researchers have discovered that inducing ubiquitin-mediated degradation of mutant EZH2 could provide a more effective treatment strategy for haematologic malignancies.
Using virtual screening, researchers have discovered several natural compounds that could inhibit the SARS-CoV-2 main protease.